METASTATIC NON SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR therapy takes on Drug-Resistant lung cancer in liver
Disease control Not yet recruitingThis early-stage trial tests a new gene-editing drug called EDB-102 in 15 people with advanced non-small cell lung cancer that has spread to the liver and no longer responds to standard targeted therapy. The drug uses CRISPR technology to target and disable a specific cancer-caus…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Morning infusions may boost lung cancer treatment
Disease control Not yet recruitingThis study looks at whether giving pembrolizumab infusions in the morning improves outcomes for people with metastatic non-small cell lung cancer. 58 participants will be randomly assigned to morning or standard scheduling. The goal is to see if timing affects how long the cancer…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New therapy aims to ease emotional toll of advanced lung cancer
Symptom relief Not yet recruitingThis study tests a program called LiveWell, which teaches emotional coping skills to people with metastatic lung cancer who are feeling anxious or depressed. About 80 participants will either take the program or receive usual care. The goal is to see if the program is practical, …
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC